HK1045102A1 - 藥物配方 - Google Patents
藥物配方Info
- Publication number
- HK1045102A1 HK1045102A1 HK02104881.2A HK02104881A HK1045102A1 HK 1045102 A1 HK1045102 A1 HK 1045102A1 HK 02104881 A HK02104881 A HK 02104881A HK 1045102 A1 HK1045102 A1 HK 1045102A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/301,838 US20020006433A1 (en) | 1999-04-29 | 1999-04-29 | Pharmaceutical formulations |
PCT/US2000/011592 WO2000066169A1 (en) | 1999-04-29 | 2000-04-28 | Pharmaceutical formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1045102A1 true HK1045102A1 (zh) | 2002-11-15 |
Family
ID=23165119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02104881.2A HK1045102A1 (zh) | 1999-04-29 | 2002-06-28 | 藥物配方 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20020006433A1 (zh) |
EP (1) | EP1173216A4 (zh) |
JP (1) | JP2002543160A (zh) |
AR (1) | AR023781A1 (zh) |
AU (1) | AU4977300A (zh) |
CO (1) | CO5170455A1 (zh) |
HK (1) | HK1045102A1 (zh) |
TW (1) | TW570804B (zh) |
WO (1) | WO2000066169A1 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030109503A1 (en) * | 1995-06-06 | 2003-06-12 | Smithkline Beecham P.L.C. | Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
US7250176B1 (en) * | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
AU2001292185A1 (en) | 2000-10-12 | 2002-04-22 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
AU2005215147B2 (en) * | 2004-02-24 | 2011-05-26 | Sandoz Ag | Amoxicillin instant granulate |
SI1818057T1 (sl) * | 2006-02-09 | 2010-08-31 | Teva Pharma | Stabilne farmacevtske formulacije montelukast natrija |
PL3046548T3 (pl) * | 2013-09-20 | 2020-07-13 | Centrient Pharmaceuticals Netherlands B.V. | Tabletka zawierająca krospowidon |
US9254261B2 (en) | 2014-03-03 | 2016-02-09 | Sandoz Ag | Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2061623T3 (es) * | 1987-03-02 | 1994-12-16 | Brocades Pharma Bv | Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico. |
GB8909793D0 (en) * | 1989-04-28 | 1989-06-14 | Beecham Group Plc | Pharmaceutical formulation |
GB9109862D0 (en) * | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
SI9200139A (en) * | 1992-07-08 | 1994-03-31 | Lek Tovarna Farmacevtskih | New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them |
-
1999
- 1999-04-29 US US09/301,838 patent/US20020006433A1/en not_active Abandoned
-
2000
- 2000-04-27 AR ARP000102011A patent/AR023781A1/es unknown
- 2000-04-27 TW TW089108021A patent/TW570804B/zh active
- 2000-04-27 CO CO00030256A patent/CO5170455A1/es not_active Application Discontinuation
- 2000-04-28 JP JP2000615053A patent/JP2002543160A/ja not_active Withdrawn
- 2000-04-28 AU AU49773/00A patent/AU4977300A/en not_active Abandoned
- 2000-04-28 WO PCT/US2000/011592 patent/WO2000066169A1/en not_active Application Discontinuation
- 2000-04-28 EP EP00931975A patent/EP1173216A4/en not_active Withdrawn
-
2002
- 2002-06-28 HK HK02104881.2A patent/HK1045102A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20020006433A1 (en) | 2002-01-17 |
EP1173216A4 (en) | 2004-09-29 |
WO2000066169A1 (en) | 2000-11-09 |
JP2002543160A (ja) | 2002-12-17 |
AR023781A1 (es) | 2002-09-04 |
TW570804B (en) | 2004-01-11 |
EP1173216A1 (en) | 2002-01-23 |
AU4977300A (en) | 2000-11-17 |
CO5170455A1 (es) | 2002-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG79255A1 (en) | Pharmaceutical formulations | |
IL147756A0 (en) | Preserved pharmaceutical formulations | |
GB0028088D0 (en) | Pharmaceutical compositions | |
GB0001662D0 (en) | Pharmaceutical compositions | |
MXPA01012478A (es) | Formulaciones farmaceuticas mejoradas. | |
AU6715600A (en) | Pharmaceutical formulations | |
EP1173216A4 (en) | PHARMACEUTICAL FORMULATIONS | |
AU1385801A (en) | Pharmaceutical formulations | |
GB9909154D0 (en) | Pharmaceutical formulation | |
GB9930578D0 (en) | Pharmaceutical formulations | |
GB9906126D0 (en) | Pharmaceutical formulations | |
EP1221941A4 (en) | PHARMACEUTICAL FORMULATIONS POWDER | |
GB9926251D0 (en) | Pharmaceutical formulation | |
GB9911826D0 (en) | Pharmaceutical formulations | |
GB9905983D0 (en) | Pharmaceutical formulations | |
GB9903177D0 (en) | Pharmaceutical formulations | |
GB9921396D0 (en) | Pharmaceutical formulation | |
GB9917772D0 (en) | Pharmaceutical formulation | |
GB9910636D0 (en) | Pharmaceutical formulation | |
GB9919840D0 (en) | Pharmaceutical formulation | |
GB9917777D0 (en) | Pharmaceutical formulation | |
GB9930878D0 (en) | Pharmaceutical formulation | |
GB9927685D0 (en) | Pharmaceutical formulation | |
GB9922187D0 (en) | Pharmaceutical formulation | |
GB9930700D0 (en) | Pharmaceutical formulation |